Literature DB >> 12695469

DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial.

H J G H Mulder, P P van Geel, M J Schalij, W H van Gilst, A H Zwinderman, A V G Bruschke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695469      PMCID: PMC1767618          DOI: 10.1136/heart.89.5.557

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans.

Authors:  R Butler; A D Morris; B Burchell; A D Struthers
Journal:  Hypertension       Date:  1999-05       Impact factor: 10.190

2.  Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients.

Authors:  F Perticone; R Ceravolo; R Maio; G Ventura; A Zingone; N Perrotti; P L Mattioli
Journal:  Hypertension       Date:  1998-04       Impact factor: 10.190

3.  Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial.

Authors:  H J Mulder; M J Schalij; B Kauer; R F Visser; P R van Dijkman; J W Jukema; A H Zwinderman; A V Bruschke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

Authors:  H Schunkert; H W Hense; S R Holmer; M Stender; S Perz; U Keil; B H Lorell; G A Riegger
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

  4 in total
  2 in total

1.  Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population.

Authors:  Ipsita Choudhury; R Jothimalar; Arun Kumar Patra
Journal:  Indian J Clin Biochem       Date:  2012-05-05

2.  ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation.

Authors:  Georgios Kitsios; Elias Zintzaras
Journal:  BMC Med Genet       Date:  2009-06-04       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.